Jewell Marcus 4
Research Summary
AI-generated summary
Cellebrite (CLBT) Global CRO Jewell Marcus Sells 383 Shares
What Happened
Jewell Marcus, Global Chief Revenue Officer of Cellebrite DI Ltd. (CLBT), sold 383 shares on May 12, 2026, in open-market transactions for a total of approximately $4,983. The reported weighted-average price was $13.01 per share (individual sale prices ranged $12.84–$13.175). This was a sale tied to vested restricted stock units and related tax obligations, not a purchase (sales are often routine).
Key Details
- Transaction date: May 12, 2026 (filed on May 14, 2026). Filing appears timely under Form 4 rules.
- Amount: 383 shares sold; total proceeds ≈ $4,983.
- Price: Weighted average $13.01; individual trades ranged $12.84–$13.175. Reporting person will provide per-price breakdown on request (per footnote).
- Reason/footnotes: Shares originated from RSUs granted Feb 11, 2025; the disposition is associated with tax withholding obligations upon vesting (Footnote F1). Footnote F2 explains the weighted-average pricing and multiple trade prices.
- Shares owned after transaction: Not disclosed in the provided filing.
Context
This sale was associated with RSU vesting and tax obligations, a common and routine reason insiders sell shares. Such sales do not necessarily indicate a change in the insider’s view of the company; purchases generally carry more weight as a bullish signal.